Treatment effect of nafamostat mesylate in patients with COVID-19 pneumonia: study protocol for a randomized controlled trial

BACKGROUND: This study is designed to evaluate the main hypothesis that nafamostat mesilate with standard therapy improves the severity and mortality rate in patients with COVID-19 pneumonia. METHODS: We conduct a randomized, open type, multi-institute/center, 2-group clinical trial with COVID-19 pn...

Descripción completa

Detalles Bibliográficos
Autores principales: Moon, Kyunglan, Hong, Kyung-Wook, Bae, In-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609248/
https://www.ncbi.nlm.nih.gov/pubmed/34814935
http://dx.doi.org/10.1186/s13063-021-05760-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8609248/
https://www.ncbi.nlm.nih.gov/pubmed/34814935
http://dx.doi.org/10.1186/s13063-021-05760-1

Ejemplares similares